微型网状结构支架的力学性能研究

冠状动脉支架为圆柱形微型网状结构，直径1mm，厚度0．1mm，长度10～16mm。在经皮冠状动脉介入PCI治疗中由球囊充气撑开到直径为2．5～3．5mm的支架，在血管内承受血管壁回弹压力。为了保持血液流通支架必须保持其几何圆形。这是一个结构弹塑性稳定性问题。但是目前国际上对于支架的力学性能质量指标主要以强度性能评定而不涉及支架屈曲性能是不妥的。本文对于支架的强度和屈曲性能进行了全面的理论分析和实验研究，自行研制了智能式电子检测仪成功地对微型网状结构支架的强度和屈曲性能实现了实测实验研究。由于微型支架的离散型网状结构的特点，在实验中出现一些特殊的屈曲现象。本文研究结果对于支架的形状与性能设计的改进和力学性能质量标准规范的制订具有重要意义。     

Magnetic microcapsules for targeted delivery of anticancer drugs

To achieve targeted distribution of anticancer drugs with sustained activity, ferromagnetic ethylcellulose microcapsules containing an anticancer drug, mitomycin C (FM-MMC-mc), were prepared by a method based on phase separation principles. Two prototypes of FM-MMC-mc were made: one with the drug as the core and zinc ferrite on its capsular surface (outer type); the other with both the drug and zinc ferrite as the core (inner type). Both preparations provided a sustained-release property and a sensitive response to conventional magnetic force, although certain differences in the release rate of drug, magnetic responsiveness, and particle size were found between the two dosage forms. Animal studies showed that the magnetic microcapsules could be magnetically controlled in the artery and urinary bladder. VX2 tumors in the rabbit hind limb and urinary bladder were successfully treated with magnetic control of FM-MMC-mc. Pharmacokinetic study revealed that the targeting of the microcapsules markedly enhanced the drug absorption into the surrounding tissues for a prolonged period of time. The results indicate the feasibility and effectiveness of the magnetic microcapsules as a targeted drug delivery system.     

Investigation Driven by Network Pharmacology on Potential Components and Mechanism of DGS,a Natural Vasoprotective Combination,for the Phytotherapy of Coronary Artery Disease

Phytotherapy offers obvious advantages in the intervention of Coronary Artery Disease (CAD), but it is difficult to clarify the working mechanisms of the medicinal materials it uses. DGS is a natural vasoprotective combination that was screened out in our previous research, yet its potential components and mechanisms are unknown. Therefore, in this study, HPLC-MS and network pharmacology were employed to identify the active components and key signaling pathways of DGS. Transgenic zebrafish and HUVECs cell assays were used to evaluate the effectiveness of DGS. A total of 37 potentially active compounds were identified that interacted with 112 potential targets of CAD. Furthermore, PI3K-Akt, MAPK, relaxin, VEGF, and other signal pathways were determined to be the most promising DGS-mediated pathways. NO kit, ELISA, and Western blot results showed that DGS significantly promoted NO and VEGFA secretion via the upregulation of VEGFR2 expression and the phosphorylation of Akt, Erk1/2, and eNOS to cause angiogenesis and vasodilation. The result of dynamics molecular docking indicated that Salvianolic acid C may be a key active component of DGS in the treatment of CAD. In conclusion, this study has shed light on the network molecular mechanism of DGS for the intervention of CAD using a network pharmacology-driven strategy for the first time to aid in the intervention of CAD.     

经腹彩色多普勒超声检查对子宫内膜异位症的诊断价值

本研究选取我院100例子宫内膜异位症患者作为病例组、同期健康妇女100例作为对照组,探讨了经腹彩色多普勒超声检查对子宫内膜异位症患者子宫动脉血流特征、子宫特征的诊断价值.结果显示,病例组的子宫体积、子宫内膜厚度测定值均大于对照组(P＜0.05);摆动子宫颈后,病例组的EDV测定值低于对照组,RI测定值大于对照组(P＜(...     

兔VX2移植肝癌及隔离灌注模型建立方法探究

应用开腹瘤块包埋法建立了兔移植肝癌模型,探讨了改良动脉插管技术及提高隔离灌注模型建立的成功率.采用的方法是将实验兔建立移植肝癌模型10d后,按动脉插管方法随机分为3组：A组为直视下儿科静脉留置针插管;B组为显微镜下儿科静脉留置针插管;C组为直视下硬膜外麻醉导管插管.建模成功后经肝动脉灌注奥沙利铂,隔离灌注模型建立前测量肿瘤生长大小,常规病理观察肿瘤,比较插管成功率.研究结果表明：肿瘤生长良好,应用儿科静脉留置针插管成功率明显高于硬膜外麻醉导管,显微镜下插管较直视下无统计学意义,奥沙利铂浓度外周静脉显著低于流出道.由此认为采用儿科静脉留置针插管操作简单,成功率高,建立隔离灌注模型外周血药物泄漏少,阻断较完全,是一种实用的隔离灌注建立方法.     

一站式CT检查系统在急性胸痛患者干预方案中的应用

本研究探讨一站式CT检查系统在急性胸痛患者管理中干预方案的应用。将符合急性胸痛患者49例纳入研究,采用自动触发方式采集患者上胸部volume数据集和心胸部volume数据集,经过处理后获得胸主动脉、冠状动脉、肺动脉及全胸部图像。本研究中,测量结果发现平均CT值主动脉弓是(332±51)Hu,升主动脉是(435±53)Hu,肺动脉干是(491±93)Hu,降主动脉是(454±70)Hu,而左冠状动脉和右冠状动脉分别是(425±60)Hu、(415±62)Hu。病变鉴定发现,急性肺栓塞12例,主动脉弓动脉粥样硬化斑块破裂8例,肺组织实变4例,慢性肺栓塞伴右心衰竭2例,胸腔积液2例,左冠状动脉非关键性狭窄11例,右冠状动脉非关键性狭窄7例,心包积液2例,复合解剖畸形1例。总之,本研究通过一站式CT检查系统对急性胸痛患者干预方案的制定提供了重要指导。     

miR-130a和miR-125b在川崎病外周血细胞中的表达及意义

目的 通过检测miR-130a 和miR-125b 在伴或不伴冠脉扩张（CAD）川崎病（KD）患儿与正常健康儿童外周血单核细胞（PBMC）中的表达差异,探讨两者可否作为KD 和CAD诊断及预后评估的全新血清生物标志物。方法 利用基因芯片技术筛选出KD 患儿与正常健康儿童之前具有差异表达的miRNAs,通过生物信息学分析,确定候选基因。进一步选取KD 患儿30 例（伴或不伴CAD 各15 例）、正常健康儿童15 例,采用茎环RT-PCR 的方法,验证候选基因miR-130a 和miR-125b 在PBMC 中的表达情况。结果 （1）通过基因芯片技术,分析KD 患儿与正常健康儿童PBMC 中存在明显差异表达的miRNA 共63 条,经过生物信息学分析,确定候选基因;（2）通过茎环RT-PCR 验证发现miR-130a 和miR-125b 在患儿IVIG 治疗前表达明显下调,而IVIG治疗后表达明显上调（P＜0.05）;（3）伴CAD 的KD 患儿miR-130a 及miR-125b 表达较不伴CAD 明显升高,且呈正相关性（R2 =0.734,mir-130a;R2 =0.709,miR-125b）;（4）ROC 曲线分析表明miR-130a（特异度87.5%和敏感度77.5%）和miR-125b（特异度83.3%和敏感度76.6%）对KD 及CAD 的判断有较高的特异度和敏感度。结论 PBMC 中的miR-130a 和miR-125b 参与了KD的发生与发展,可作为KD 及CAD诊断及预后评估的一项全新血清生物标志物,并为KD冠脉扩张的防治提供新的思路。     

急性脑梗死介入治疗术后护理

总结了15例急性脑梗死患者动脉介入治疗术后的护理体会,阐述了术后在心理护理、呼吸道护理、持续抗凝治疗、防止脑出血以及出院指导、康复锻炼等方面所采取的措施,这些是预防重要并发症发生,使患者顺利康复的重要因素。     

血清钙、镁和微量元素与冠心病

综述了钙、镁和微量元素在动脉粥样硬化、冠心病(包括冠状动脉痉挛)研究的相关报道,以进一步研究钙、镁和微量元素与冠状动脉痉挛的关系。     

降温速率对低温保存动脉粘弹性的影响

使用DMA测定了3种降温速率低温保存的家兔颈总动脉的蠕变曲线.结果表明:1.5℃/min降温速率低温保存后,血管的粘弹性最接近新鲜对照组;而对应降温速率1.5,5,10℃/min,血管粘弹性依次降低.动脉的粘弹性极有可能是评估其低温保存效果的潜在评价指标.